May 12, 2022
Cancer is the second leading cause of death in the United States, killing over 600,000 people a year. The good news is that not all cancer diagnoses are fatal (or even harmful). The key is to catch cancer in its earliest phase before it can grow, spread, and cause harm. For example, someone with precancerous colon cells may have those abnormal cells removed with a routine procedure.
The survival rate is almost 100%. Even if colon cancer has progressed into stage one cancer, the five-year survival rate is 95%. However, once that same cancer has metastasized and spread to other organs, the five-year survival rate drops to only 14%.
That’s why the most significant cancer-breakthroughs are not always treatments, but screening programs. Tests that detect cancer early are a true lifesaver.
"Early Detection is a lifesaver and can increase cancer survival rate to almost 100 %.
The Galleri® test, implemented by Fountain Life, can detect a cancer signal across more than 50 types of cancer, most of which are not typically screened for by other tests. A simple blood test looks for the DNA markers that tumor cells shed and can flag cancers in their infancy – as early as stages 0 to 1.
The multi-cancer early detection blood test is designed to be used alongside current screening programs. While the long-range goal is for early cancer screening to become the standard of care for everyone, Fountain Life is proud to be an early adopter and to offer this invaluable service to our members and Precision Diagnostics clients.
As a part of our plan to democratize health care and take medicine from proactive to reactive, we encourage everyone to take this ground-breaking test annually.
Sign up for this innovative early detection blood test today!